These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33788339)

  • 1. ATP-Responsive Smart Hydrogel Releasing Immune Adjuvant Synchronized with Repeated Chemotherapy or Radiotherapy to Boost Antitumor Immunity.
    Sun L; Shen F; Tian L; Tao H; Xiong Z; Xu J; Liu Z
    Adv Mater; 2021 May; 33(18):e2007910. PubMed ID: 33788339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programming Injectable DNA Hydrogels Yields Tumor Microenvironment-Activatable and Immune-Instructive Depots for Augmented Chemo-Immunotherapy.
    Fan Y; Zhan M; Liang J; Yang X; Zhang B; Shi X; Hu Y
    Adv Sci (Weinh); 2023 Oct; 10(29):e2302119. PubMed ID: 37541435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses.
    Chao Y; Liang C; Tao H; Du Y; Wu D; Dong Z; Jin Q; Chen G; Xu J; Xiao Z; Chen Q; Wang C; Chen J; Liu Z
    Sci Adv; 2020 Mar; 6(10):eaaz4204. PubMed ID: 32181368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy.
    Ma B; Ma Y; Deng B; Xiao P; Huang P; Wang D; Liu L
    J Nanobiotechnology; 2023 May; 21(1):171. PubMed ID: 37237292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable polypeptide-engineered hydrogel depot for amplifying the anti-tumor immune effect induced by chemo-photothermal therapy.
    Hou XL; Dai X; Yang J; Zhang B; Zhao DH; Li CQ; Yin ZY; Zhao YD; Liu B
    J Mater Chem B; 2020 Sep; 8(37):8623-8633. PubMed ID: 32821893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
    He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency.
    Han Y; Ding B; Zhao Z; Zhang H; Sun B; Zhao Y; Jiang L; Zhou J; Ding Y
    Biomaterials; 2018 Dec; 185():205-218. PubMed ID: 30245388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy.
    Jiang M; Chen W; Yu W; Xu Z; Liu X; Jia Q; Guan X; Zhang W
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43963-43974. PubMed ID: 34506118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable Supramolecular Hydrogel for Locoregional Immune Checkpoint Blockade and Enhanced Cancer Chemo-Immunotherapy.
    Liu M; Cao Z; Zhang R; Chen Y; Yang X
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33874-33884. PubMed ID: 34275267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
    Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
    Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Assembled Immunostimulatory Tetrahedral Framework Nucleic Acid Vehicles for Tumor Chemo-immunotherapy.
    Liu M; Hao L; Zhao D; Li J; Lin Y
    ACS Appl Mater Interfaces; 2022 Aug; 14(34):38506-38514. PubMed ID: 35973112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environment-responsive dendrobium polysaccharide hydrogel embedding manganese microsphere as a post-operative adjuvant to boost cascaded immune cycle against melanoma.
    Gao N; Huang Y; Jing S; Zhang M; Liu E; Qiu L; Huang J; Muhitdinov B; Huang Y
    Theranostics; 2024; 14(10):3810-3826. PubMed ID: 38994034
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Cell Oncol (Dordr); 2020 Dec; 43(6):1203-1214. PubMed ID: 32797385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-Step Self-Assembly of Multifunctional DNA Nanohydrogels: An Enhanced and Harmless Strategy for Guiding Combined Antitumor Therapy.
    Wei H; Zhao Z; Wang Y; Zou J; Lin Q; Duan Y
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46479-46489. PubMed ID: 31747745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable Micelle-Incorporated Hydrogels for the Localized Chemo-Immunotherapy of Breast Tumors.
    Qin X; He L; Feng C; Fan D; Liang W; Wang Q; Fang J
    ACS Appl Mater Interfaces; 2021 Oct; 13(39):46270-46281. PubMed ID: 34550685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Activated Size-Enlargeable Bioinspired Lipoproteins Access Cancer Cells in Tumor to Elicit Anti-Tumor Immune Responses.
    Li J; Wang H; Wang Y; Gong X; Xu X; Sha X; Zhang A; Zhang Z; Li Y
    Adv Mater; 2020 Sep; 32(38):e2002380. PubMed ID: 33252171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer nutritional-immunotherapy with NIR-II laser-controlled ATP release based on material repurposing strategy.
    Lu J; Wang Y; Gao X; Li Y; Ufurahi-Pambe N; Fahad A; Jin Z; He Z; Guo Z; Xie W; Wang S; Sun X; Wang X; Yu J; Che S; Zhang G; Wei Y; Zhao L
    J Mater Chem B; 2024 May; 12(19):4629-4641. PubMed ID: 38666407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.